Rati Kailash Prasad Tripathi (Rati Tripathi, Rati K P Tripathi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Trypanosoma Cruzi

Structure Activity Relationship

Top Venues

Current computer-aided drug design

Medicinal research reviews

Current topics in medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ishan I Panchal, Rati Kailash Prasad Tripathi, Mange Ram Yadav, Meet Valera, Kinjal Parmar
Design, Synthesis, and Biological and in silico Evaluation of Novel Indazole-pyridine Hybrids for the Treatment of Breast Cancer. Current computer-aided drug design (2024)
Vaishali Pavalbhai Patel, Rati Kailash Prasad Tripathi, Abhay Dharamsi
Computational Exploration of Isatin Derivatives for InhA Inhibition in Tuberculosis: Molecular Docking, MD Simulations and ADMET Insights. Current computer-aided drug design (2024)
Ishan I Panchal, Rati Kailash Prasad Tripathi, Kinjal Parmar, Mange Ram Yadav
Discovery of Tropomyosin Receptor Kinase Inhibitors as New Generation Anticancer Agents: A Review. Current topics in medicinal chemistry (2023)
Rati Kailash Prasad Tripathi, Rajarshi Dey, Nirupam Das
Identification of natural lead molecules as potential Trypanosoma cruzi cruzipain inhibitors and decoding the interaction mechanism for the treatment of Chagas disease: a computational biology analysis. Natural product research (2023)
Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan
Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs. Archiv der Pharmazie 353 (9) (2020)
Ashish D Patel, Thopallada Y Pasha, Paras Lunagariya, Umang Shah, Tushar Bhambharoliya, Rati Kailash Prasad Tripathi
A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents. ChemMedChem 15 (13) (2020)
Rati Kailash Prasad Tripathi, Senthil Raja Ayyannan
Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. Medicinal research reviews 39 (5) (2019)